Werlinich Asset Management, LLC Johnson & Johnson Transaction History

Werlinich Asset Management, LLC

$161 Billion
Q2 2024

A detailed history of Werlinich Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Werlinich Asset Management, LLC holds 13,130 shares of JNJ stock, worth $2.17 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

13,130

Previous 13,080 0.38%

Holding current value

$2.17 Million

Previous $2.07 Billion 7.35%

% of portfolio

1.19%

Previous 1.35%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$144.38 - $157.78 $7,219 - $7,889	50 Added 0.38%	13,130 $1.91 Billion
Q1 2024 Apr 11, 2024	BUY	$155.22 - $162.74 $187,816 - $196,915	1,210 Added 10.19%	13,080 $2.07 Billion
Q4 2023 Jan 09, 2024	SELL	$145.6 - $158.88 $105,705 - $115,346	-726 Reduced 5.76%	11,870 $1.86 Billion
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $14,173 - $15,877	91 Added 0.73%	12,596 $1.96 Billion
Q2 2023 Nov 13, 2023	BUY	$154.35 - $166.11 $92,610 - $99,666	600 Added 5.04%	12,505 $2.07 Billion
Q1 2023 Nov 13, 2023	BUY	$151.05 - $180.26 $56,341 - $67,236	373 Added 3.23%	11,905 $1.85 Billion
Q4 2022 Nov 13, 2023	BUY	$160.2 - $179.79 $4,004 - $4,494	25 Added 0.22%	11,532 $2.04 Billion
Q3 2022 Nov 13, 2023	SELL	$161.33 - $179.52 $16,133 - $17,952	-100 Reduced 0.86%	11,507 $1.88 Billion
Q1 2022 Nov 13, 2023	SELL	$158.14 - $179.59 $24,986 - $28,375	-158 Reduced 1.34%	11,607 $2.06 Billion
Q4 2021 Nov 13, 2023	BUY	$155.93 - $173.01 $77,965 - $86,505	500 Added 4.44%	11,765 $2.01 Billion
Q1 2021 Nov 13, 2023	BUY	$153.07 - $170.48 $1.72 Million - $1.92 Million	11,265 New	11,265 $1.85 Billion

Others Institutions Holding JNJ

# of Institutions

4,158

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Werlinich Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Werlinich Asset Management, LLC with notifications on news.

Account

Werlinich Asset Management, LLC Johnson & Johnson Transaction History